Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engineering and design considerations for next-generation snakebite antivenoms
Cecilie Knudsen, Line Ledsgaard, Rasmus Ibsen Dehli, et al.
Toxicon (2019) Vol. 167, pp. 67-75
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Causes and Consequences of Snake Venom Variation
Nicholas R. Casewell, Timothy N. W. Jackson, Andreas H. Laustsen, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 8, pp. 570-581
Open Access | Times Cited: 279
The Indian cobra reference genome and transcriptome enables comprehensive identification of venom toxins
Kushal Suryamohan, Sajesh P Krishnankutty, Joseph Guillory, et al.
Nature Genetics (2020) Vol. 52, Iss. 1, pp. 106-117
Open Access | Times Cited: 160
Scorpion Venom: Detriments and Benefits
Shirin Ahmadi, Julius M. Knerr, Lídia Argemí, et al.
Biomedicines (2020) Vol. 8, Iss. 5, pp. 118-118
Open Access | Times Cited: 121
The Urgent Need to Develop Novel Strategies for the Diagnosis and Treatment of Snakebites
Harry F. Williams, Harry J. Layfield, Thomas M. Vallance, et al.
Toxins (2019) Vol. 11, Iss. 6, pp. 363-363
Open Access | Times Cited: 110
History of Envenoming Therapy and Current Perspectives
Manuela Berto Pucca, Felipe Augusto Cerni, Rahel Janke, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 99
The Search for Natural and Synthetic Inhibitors That Would Complement Antivenoms as Therapeutics for Snakebite Envenoming
José Marı́a Gutiérrez, Laura-Oana Albulescu, Rachel H. Clare, et al.
Toxins (2021) Vol. 13, Iss. 7, pp. 451-451
Open Access | Times Cited: 64
Old World Vipers—A Review about Snake Venom Proteomics of Viperinae and Their Variations
Maik Damm, Benjamin-Florian Hempel, Roderich D. Süßmuth
Toxins (2021) Vol. 13, Iss. 6, pp. 427-427
Open Access | Times Cited: 58
Snakebite drug discovery: high-throughput screening to identify novel snake venom metalloproteinase toxin inhibitors
Rachel H. Clare, Charlotte A. Dawson, Adam Westhorpe, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 12
Revolutionizing snakebite care with novel antivenoms: Breakthroughs and barriers
Samuel Odo Uko, Ibrahim Malami, Kasimu Ghandi Ibrahim, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e25531-e25531
Open Access | Times Cited: 8
Clinical management of snakebite envenoming: Future perspectives
Muhammad Hamza, Cecilie Knudsen, Christeine Ariaranee Gnanathasan, et al.
Toxicon X (2021) Vol. 11, pp. 100079-100079
Open Access | Times Cited: 45
Strategies for Heterologous Expression, Synthesis, and Purification of Animal Venom Toxins
Esperanza Rivera‐de‐Torre, Charlotte Rimbault, Timothy P. Jenkins, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 9
Open Access | Times Cited: 34
Plant-Derived Toxin Inhibitors as Potential Candidates to Complement Antivenom Treatment in Snakebite Envenomations
Asenate Aline Xavier Adrião, Aline O. dos Santos, Emilly J. S. P. de Lima, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
Snake three-finger α-neurotoxins and nicotinic acetylcholine receptors: molecules, mechanisms and medicine
Selvanayagam Nirthanan
Biochemical Pharmacology (2020) Vol. 181, pp. 114168-114168
Closed Access | Times Cited: 47
Development of Nanobodies Against Hemorrhagic and Myotoxic Components of Bothrops atrox Snake Venom
Henri Bailón, Verónica Olga Yaniro Coronel, Omar Cáceres, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 44
Neutralizing Effects of Small Molecule Inhibitors and Metal Chelators on Coagulopathic Viperinae Snake Venom Toxins
Chunfang Xie, Laura-Oana Albulescu, Mátyás A. Bittenbinder, et al.
Biomedicines (2020) Vol. 8, Iss. 9, pp. 297-297
Open Access | Times Cited: 41
Promoting co-existence between humans and venomous snakes through increasing the herpetological knowledge base
Anita Malhotra, Wolfgang Wüster, John Benjamin Owens, et al.
Toxicon X (2021) Vol. 12, pp. 100081-100081
Open Access | Times Cited: 36
Generation of Multivalent Nanobody-Based Proteins with Improved Neutralization of Long α-Neurotoxins from Elapid Snakes
Jack Wade, Charlotte Rimbault, Hanif Ali, et al.
Bioconjugate Chemistry (2022) Vol. 33, Iss. 8, pp. 1494-1504
Open Access | Times Cited: 25
Cost of Manufacturing for Recombinant Snakebite Antivenoms
Timothy P. Jenkins, Andreas H. Laustsen
Frontiers in Bioengineering and Biotechnology (2020) Vol. 8
Open Access | Times Cited: 37
Terrestrial venomous animals, the envenomings they cause, and treatment perspectives in the Middle East and North Africa
Timothy P. Jenkins, Shirin Ahmadi, Mátyás A. Bittenbinder, et al.
PLoS neglected tropical diseases (2021) Vol. 15, Iss. 12, pp. e0009880-e0009880
Open Access | Times Cited: 29
In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus
Stefanie K. Menzies, Rachel H. Clare, Chunfang Xie, et al.
Toxicon X (2022) Vol. 14, pp. 100118-100118
Open Access | Times Cited: 21
Unraveling snake venom phospholipase A2: an overview of its structure, pharmacology, and inhibitors
Ganesh H. Sampat, Kashinath Hiremath, Jagadeesh Dodakallanavar, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1454-1473
Closed Access | Times Cited: 12
Towards better antivenoms: navigating the road to new types of snakebite envenoming therapies
Suthimon Thumtecho, Nick J. Burlet, Anne Ljungars, et al.
˜The œJournal of venomous animals and toxins including tropical diseases (2023) Vol. 29
Open Access | Times Cited: 12
Exploring the Utility of ssDNA Aptamers Directed against Snake Venom Toxins as New Therapeutics for Snakebite Envenoming
Nessrin Alomran, Raja Chinnappan, Jaffer Alsolaiss, et al.
Toxins (2022) Vol. 14, Iss. 7, pp. 469-469
Open Access | Times Cited: 15
A Quest for a Universal Plasma-Derived Antivenom Against All Elapid Neurotoxic Snake Venoms
Kavi Ratanabanangkoon
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 20
Advances in the Therapeutic Application of Small-Molecule Inhibitors and Repurposed Drugs against Snakebite
Upasana Puzari, Pedro Alexandrino Fernandes, Ashis K. Mukherjee
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 19, pp. 13938-13979
Closed Access | Times Cited: 20
Page 1 - Next Page

Scroll to top